Form 4: Incyte EVP & General Counsel Sheila Denton Reports Stock and Option Awards

Sheila A. Denton, EVP & General Counsel of Incyte Corp, reports the acquisition of restricted stock units and stock options.

Summary

• On July 15, 2024, Sheila A. Denton, EVP & General Counsel of Incyte Corp, reported transactions related to Incyte stock.
• Denton was awarded 5,955 restricted stock units (RSUs) that vest 25% annually over four years.
• These RSUs can be settled for common stock on a one-for-one basis.
• Denton also acquired 13,323 employee stock options with an exercise price of $64.25.
• These options become exercisable in 37 installments, with 25% vesting after one year and the remainder vesting monthly over three years.
• Following these transactions, Denton beneficially owns 32,479 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
• Denton also owns 13,323 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports standard executive compensation practices. It's neither overly positive nor negative from an investment perspective.

Positives

• The grant of RSUs and stock options to a key executive like the EVP & General Counsel can be seen as an incentive to align their interests with the company's long-term performance.

Industry Context

Stock and option awards are a common practice in the pharmaceutical industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are standard practice among publicly traded biopharmaceutical companies like Incyte.
• Companies such as Gilead Sciences, Amgen, and Vertex Pharmaceuticals also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules and exercise prices are generally in line with industry norms, designed to reward long-term value creation.

Stakeholder Impact

• The stock and option awards could potentially dilute existing shareholders' equity if the options are exercised and RSUs are converted to common stock.

Key Dates